Soluble guanylate cyclase deficiency selectively abolishes NO-mediated pulmonary vasodilation and increases the pulmonary vascular remodeling response to chronic hypoxia
Pieter Vermeersch(Universitair Ziekenhuis Leuven), Stefan Janssens(Maastricht University), Melissa Swinnen(KU Leuven), Mieke Dewerchin(Vlaams Instituut voor Biotechnologie), Glenn Marsboom(Johnson & Johnson (United States)), KD Bloch, Fumito Ichinose(Harvard University), Peter Brouckaert(Vlaams Instituut voor Biotechnologie), Marijke Pellens(Ghent University), Péter Pokreisz(Ghent University), ES Buys, Hilde Gillijns(Ghent University)
Ghent University Academic Bibliography (Ghent University)
October 1, 2005
Cited by 0
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer
|The FASEB Journal|2012|606
Inhaled Nitric Oxide
|Circulation|2004|533